Free delivery for orders over 69.99 euro.

Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

Free delivery for purchases over 69.99 €

DPD courier 5.99 € Bpost point 7.99 € Bpost 7.49 € DPD point 3.49 € GLS courier 4.99 €

Contact

How to shop

Help

My account

▸ Empty :-(

Free delivery for orders over 69.99 euro.

Adenosinergic System

Name: Adenosinergic System
Brand: Springer International Publishing AG
SKU: 09301187
Price: 153.91 EUR
Availability: InStock
Author: Micaela Morelli
ISBN: 9783319202723

A Non-Dopaminergic Target in Parkinson's Disease

Micaela Morelli

Nicola Simola

Jadwiga Wardas

Language

English

Book Hardback

Libristo code: 09301187

Publishers Springer International Publishing AG, September 2015

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease... Full description

Libristo code: 09301187

373 b

153.91 €

In stock at our supplier Shipping in 10-13 days

Up to 30 days for returns

Customers also purchased

Workshop Kunst Herbert Schöttle

Paperback

41.95 €

alfabeto simbolico degli animali Francesco Zambon

Paperback

26.82 €

La batalla de Francia 50Minutos

Adobe ePub DRM

11.49 €

Otto Placht - Sol Silvestre Otto Placht

Paperback

7.15 €

Měla by to být blondýnka s modrýma očima/Blondinka s golubymi glazami Anton Pavlovič Čechov

Hardback

4.53 €

Die Reise einer jungen Anarchistin in Griechenland. Marlene Streeruwitz

Paperback

9.07 €

Mein Mathebuch - Ausgabe B für Bayern - 3. Jahrgangsstufe Brigitte Dangelat-Bergner

Paperback

11.69 €

Verteilungsverfahren Ferdinand Wollenschläger

Hardback

157.95 €

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease, and (3) a study of urate as a possible biomarker and neuroprotectant.